A. Avron

发表

Evaluation of Long-Term Treatment Effect in a Type 1 Diabetes Intervention Trial: Differences After Stimulation With Glucagon or a Mixed Meal

I. Cohen, I. Raz, P. Pozzilli, 2014, Diabetes Care.

Treatment of new‐onset type 1 diabetes with peptide DiaPep277® is safe and associated with preserved beta‐cell function: extension of a randomized, double‐blind, phase II trial

I. Cohen, I. Raz, M. Metzger, 2007, Diabetes/metabolism research and reviews.

Heat‐shock protein peptide DiaPep277 treatment in children with newly diagnosed type 1 diabetes: a randomised, double‐blind phase II study

M. Phillip, D. Elias, A. Avron, 2007, Diabetes/metabolism research and reviews.

Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial.

I. Cohen, I. Raz, M. Metzger, 2001, Lancet.

IL-2 induces T cell adherence to extracellular matrix: inhibition of adherence and migration by IL-2 peptides generated by leukocyte elastase.

A. Ariel, A. Avron, R. Hershkoviz, 1998, Journal of immunology.

Leukocyte Elastase and Migration by IL-2 Peptides Generated by Adherence Extracellular Matrix: Inhibition of IL-2 Induces T Cell Adherence to

A. Ariel, A. Avron, R. Hershkoviz, 1998 .

DiaPep277® Preserves Endogenous Insulin Production by Immunomodulation in Type 1 Diabetes

I. Raz, D. Elias, A. Avron, 2006, Annals of the New York Academy of Sciences.

β-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial

I. Cohen, I. Raz, M. Metzger, 2001, The Lancet.

Mycoplasma stimulates the production of oxidative radicals by murine peritoneal macrophages

A. Avron, R. Gallily, 1995, Journal of leukocyte biology.

Heparin disaccharides inhibit tumor necrosis factor-alpha production by macrophages and arrest immune inflammation in rodents.

I. Cohen, A. Eshel, A. Avron, 1997, International immunology.

Regulation of submaxillary gland muscarinic receptors during heat acclimation.

Y. Kloog, A. Avron, R. Galron, 1985, Biochimica et biophysica acta.

Treatment of Recent-Onset Type 1 Diabetic Patients With DiaPep277: Results of a Double-Blind, Placebo-Controlled, Randomized Phase 3 Trial

A. Ziegler, I. Cohen, D. Mauricio, 2014, Diabetes Care.

Effect of alanine insertion (P′5) on the reactive centre of α1‐antitrypsin

R. Carrell, A. Avron, F. H. Reeve, 1991 .

F5 – ACTIVATION OF MACROPHAGES AND MONOCYTES BY MYCOPLASMAS

A. Avron, P. Mühlradt, R. Gallily, 1995 .

Treatment of Recent-Onset Type 1 Diabetic Patients With DiaPep277: Results of a Double-Blind, Placebo-Controlled, Randomized Phase 3 Trial

A. Ziegler, I. Cohen, D. Mauricio, 2014, Diabetes Care.

Treatment of new‐onset type 1 diabetes with peptide DiaPep277® is safe and associated with preserved beta‐cell function: extension of a randomized, double‐blind, phase II trial

I. Cohen, M. Metzger, D. Elias, 2007, Diabetes/metabolism research and reviews.